Decreased DNA methylation in acute myeloid leukemia patients with DNMT3A mutations and prognostic implications of DNA methylation

Leukemia Research

Volumn 36, Issue 9, 2012, Pages 1128-1133

  Hájková, Hana ^a   Marková, Jana ^a   Haškovec, Cedrik ^a   Šárová, Iveta ^a   Fuchs, Ota ^a   Kostečka, Arnošt ^a   Cetkovský, Petr ^a   Michalová, Kyra ^b   Schwarz, Jiří ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

AML; DNA methylation; DNMT3A mutations; Prognosis

Indexed keywords

DNA METHYLTRANSFERASE 3A; GENOMIC DNA; HOMEODOMAIN PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; CALCA GENE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RELAPSE; CANCER SURVIVAL; CDH1 GENE; CDKN2B GENE; CTNNA1 GENE; DAPK1 GENE; DNA METHYLATION; DNMT3A GENE; EGR1 GENE; ESR1 GENE; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC DIFFERENCE; HIGH RISK PATIENT; HOX GENE; HOXA1 GENE; HOXA11 GENE; HOXA13 GENE; HOXA2 GENE; HOXA4 GENE; HOXA5 GENE; HOXA6 GENE; HOXA7 GENE; HOXA9 GENE; HOXB1 GENE; HOXB13 GENE; HOXB2 GENE; HOXB3 GENE; HOXB4 GENE; HOXB5 GENE; HOXB6 GENE; HOXB7 GENE; HOXB8 GENE; HOXB9 GENE; HOXC8 GENE; HOXD10 GENE; HOXD11 GENE; HOXD13 GENE; HOXD3 GENE; HUMAN; ICAM1 GENE; MAJOR CLINICAL STUDY; MALE; MYOD1 GENE; ONCOGENE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SOCS1 GENE; TERT GENE; TIMP3 GENE; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CYTOGENETIC ANALYSIS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION, MISSENSE; PROGNOSIS; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 84864007553     PISSN: 01452126     EISSN: 18735835     Source Type: Journal    
DOI: 10.1016/j.leukres.2012.05.012     Document Type: Article

References (31)

1. Baylin S.B., Herman J.G. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 2000, 16(4):168-174.
2. Jiang Y., Dunbar A., Gondek L.P., Mohan S., Rataul M., O'Keefe C., et al. Aberrant DNA methylation is a dominant mechanism in MDS progression to AML. Blood 2009, 113(6):1315-1325.
3. Chen J., Odenike O., Rowley J.D. Leukaemogenesis: more than mutant genes. Nat Rev Cancer 2010, 10(1):23-36.
4. Rocquain J., Carbuccia N., Trouplin V., Raynaud S., Murati A., Nezri M., et al. Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1 TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias. BMC Cancer 2010, 10:401.
5. Vainchenker W., Delhommeau F., Constantinescu S.N., Bernard O.A. New mutations and pathogenesis of myeloproliferative neoplasms. Blood 2011, 118(7):1723-1735.
6. Ley T.J., Ding L., Walter M.J., McLellan M.D., Lamprecht T., Larson D.E., et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med 2010, 363(25):2424-2433.
7. Thol F., Damm F., Ludeking A., Winschel C., Wagner K., Morgan M., et al. Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia. J Clin Oncol 2011, 29(21):2889-2896.
8. Bestor T.H. The DNA methyltransferases of mammals. Hum Mol Genet 2000, 9(16):2395-2402.
9. Illingworth R.S., Bird A.P. CpG islands - 'a rough guide'. FEBS Lett 2009, 583(11):1713-1720.
10. Li E., Bestor T.H., Jaenisch R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 1992, 69(6):915-926.
11. Xu G.L., Bestor T.H., Bourc'his D., Hsieh C.L., Tommerup N., Bugge M., et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature 1999, 402(6758):187-191.
12. Hansen R.S., Wijmenga C., Luo P., Stanek A.M., Canfield T.K., Weemaes C.M., et al. The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome. Proc Natl Acad Sci U S A 1999, 96(25):14412-14417.
13. Melki J.R., Vincent P.C., Clark S.J. Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 1999, 59(15):3730-3740.
14. Toyota M., Kopecky K.J., Toyota M.O., Jair K.W., Willman C.L., Issa J.P. Methylation profiling in acute myeloid leukemia. Blood 2001, 97(9):2823-2829.
15. Arnold J.M., Cummings M., Purdie D., Chenevix-Trench G. Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas. Br J Cancer 2001, 85(9):1351-1358.
16. Griffiths E.A., Gore S.D., Hooker C.M., Mohammad H.P., McDevitt M.A., Smith B.D., et al. Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia. Epigenetics 2010, 5(7):590-600.
17. Yan X.J., Xu J., Gu Z.H., Pan C.M., Lu G., Shen Y., et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 2011, 43(4):309-315.
18. Marchesi F., Annibali O., Cerchiara E., Tirindelli M.C., Avvisati G. Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review. Crit Rev Oncol Hematol 2011, 80(3):331-346.
19. Marková J., Trnková Z., Michková P., Maaloufová J., Starý J., Cetkovský P., et al. Monitoring of minimal residual disease in patients with core binding factor acute myeloid leukemia and the impact of C-KIT FLT3, and JAK2 mutations on clinical outcome. Leuk Lymphoma 2009, 50:1448-1460.
20. Eads C.A., Danenberg K.D., Kawakami K., Saltz L.B., Blake C., Shibata D., et al. MethyLight: a high-throughput assay to measure DNA methylation. Nucleic Acids Res 2000, 28(8):E32.
21. Eads C.A., Lord R.V., Wickramasinghe K., Long T.I., Kurumboor S.K., Bernstein L., et al. Epigenetic patterns in the progression of esophageal adenocarcinoma. Cancer Res 2001, 61(8):3410-3418.
22. Friedrich M.G., Chandrasoma S., Siegmund K.D., Weisenberger D.J., Cheng J.C., Toma M.I., et al. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma. Eur J Cancer 2005, 41(17):2769-2778.
23. Ogino S., Kawasaki T., Brahmandam M., Cantor M., Kirkner G.J., Spiegelman D., et al. Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis. J Mol Diagn 2006, 8(2):209-217.
24. Kim J.H., Dhanasekaran S.M., Prensner J.R., Cao X., Robinson D., Kalyana-Sundaram S., et al. Deep sequencing reveals distinct patterns of DNA methylation in prostate cancer. Genome Res 2011, 21(7):1028-1041.
25. Marková J., Michková P., Burčková K., Březinová J., Michalová K., Dohnalová A., et al. Prognostic impact of DNMT3A mutations in patients with intermediate cytogenetic risk profile acute myeloid leukemia. Eur J Haematol 2012, 88:128-135.
26. Deneberg S., Grövdal M., Karimi M., Jansson M., Nahi H., Corbacioglu A., et al. Gene-specific and global methylation patterns predict outcome in patients with acute myeloid leukemia. Leukemia 2010, 24(5):932-941.
27. Kroeger H., Jelinek J., Komblau S.M., Bueso-Ramos C.E., Issa J.P. Increased DNA methylation is associated with good prognosis in AML. Blood 2007, 110(11):183A.
28. Lin T.C., Hou H.A., Chou W.C., Ou D.L., Yu S.L., Tien H.F., et al. CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia. Leukemia 2011, 25(1):32-40.
29. Shimamoto T., Ohyashiki J.H., Ohyashiki K. Methylation of p15(INK4b) and E-cadherin genes is independently correlated with poor prognosis in acute myeloid leukemia. Leuk Res 2005, 29(6):653-659.
30. Christiansen D.H., Andersen M.K., Pedersen-Bjergaard J. Methylation of p15(INK4B) is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 2003, 17(9):1813-1819.
31. Alvarez S., Suela J., Valencia A., Fernández A., Wunderlich M., Agirre X., et al. DNA methylation profiles and their relationship with cytogenetic status in adult acute myeloid leukemia. Plos One 2010, 5(8):e12197.